VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,676,765 | +192.4% | 58,124 | +217.8% | 0.02% | +183.3% |
Q2 2023 | $573,367 | -11.9% | 18,292 | -3.9% | 0.01% | -14.3% |
Q1 2023 | $650,702 | -28.4% | 19,026 | -36.7% | 0.01% | -30.0% |
Q4 2022 | $908,292 | +164.7% | 30,044 | +126.7% | 0.01% | +150.0% |
Q3 2022 | $343,175 | -6.9% | 13,254 | +4.1% | 0.00% | 0.0% |
Q2 2022 | $368,547 | -94.8% | 12,728 | -91.9% | 0.00% | -94.2% |
Q1 2022 | $7,098,956 | +130.9% | 157,482 | +83.4% | 0.07% | +130.0% |
Q4 2021 | $3,074,349 | – | 85,860 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |